Balakrishna, V. A., Police, A., Hiremath, R., Raj, A., Sulochana, S. P., Chandrasekhar, D. V., Mohd, Z., Bhamidipati, R. K., & Mullangi, R. (2017). Preclinical assessment of ulixertinib, a novel ERK1/2 inhibitor. ADMET and DMPK, 5(4), 212–223. https://doi.org/10.5599/admet.5.4.437